MOONLAKE IMMUNOTHERAPEUTICS

Ticker: MLTX CUSIP: 61559X104 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 239,020 Value ($000) $3,150 Avg Close $11.80 Range $6.56 - $15.55
Q3 2025
Shares 84,347 Value ($000) $605 Avg Close $52.12 Range $5.95 - $62.75
Q2 2025
Shares 80,350 Value ($000) $3,793 Avg Close $40.73 Range $31.42 - $52.88
Q1 2025
Shares 120,769 Value ($000) $4,718 Avg Close $43.09 Range $36.52 - $56.00
Q4 2024
Shares 27,918 Value ($000) $1,512 Avg Close $51.06 Range $45.24 - $58.26
Q3 2024
Shares 6,340 Value ($000) $320 Avg Close $46.86 Range $39.36 - $55.74
Q2 2024
Shares 3,267 Value ($000) $144 Avg Close $42.36 Range $37.55 - $50.28
Q1 2024
Shares 14,752 Value ($000) $741 Avg Close $54.24 Range $42.43 - $64.98
Q4 2023
Shares 641 Value ($000) $39 Avg Close $51.54 Range $35.11 - $63.77
Q3 2023
Shares 1,125 Value ($000) $64 Avg Close $55.20 Range $47.33 - $63.40
Q1 2023
Shares 7,960 Value ($000) $170 Avg Close $16.81 Range $10.50 - $25.32
Q4 2022
Shares 73,388 Value ($000) $771 Avg Close $8.89 Range $7.05 - $10.60
Q3 2022
Shares 75,664 Value ($000) $587 Avg Close $7.04 Range $5.13 - $10.27
Q2 2022
Shares 73,660 Value ($000) $387 Avg Close $6.29 Range $4.25 - $15.19